Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble

Thursday, August 28, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), Oracle Corp. (ORCL), and The Procter & Gamble Co. (PG), as well as a micro-cap stock, Comstock Holding Companies, Inc. (CHCI). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.You can read today's AWS here >>> Big Morning for Q2 Numbers: GDP +3.3%, Earnings Beats for RetailersToday's Featured Research ReportsShares of Eli Lilly have declined -4.7% over the year-to-date period against the Zacks Large Cap Pharmaceuticals industry’s decline of -0.6%. Declining sales of Trulicity, rising pricing pressure on some drugs, and potential competition in the GLP-1 diabetes/obesity market are some of Eli Lilly’s top-line headwinds. Lilly is making rapid pipeline progress in obesity and diabetes. However, data from phase III studies on its weight-loss pill, orforglipron, was mixed. However, demand for popular GLP-1 drugs, Mounjaro and Zepbound, remains strong, making them Lilly’s key top-line drivers. Launches of these drugs in new international markets and improved supply from ramped-up production led to strong sales in the first half of 2025.(You can read the full research report on Eli Lilly here >>>)Oracle’s shares have outperformed the Zacks Computer – Software industry over the year-to-date period (+43.2% vs. +16.3%). Oracle is benefiting from continued momentum from its Oracle Cloud Infrastructure business, including from winning cloud-computing contracts from AI-focused startups. ORCL’s continued investment in cloud infrastructure, comprising NetSuite Enterprise Resource Planning (ERP) and Fusion ERP, positions it well for sustained growth in the dynamic software industry.Oracle’s partnership with Amazon for Oracle Database@AWS and the general availability of Oracle Database@Google bode well. Oracle’s Gen 2 Cloud is driving artificial intelligence clientele.  The company's share buybacks and dividend policy are noteworthy.(You can read the full research report on Oracle here >>>)Shares of Procter & Gamble have declined -6.4% over the year-to-date period against the Zacks Consumer Products - Staples industry’s decline of -4.0%. Procter & Gamble’s elevated commodity costs, tariff pressures, higher interest expenses, and a fragile recovery in China continue to weigh on margins, earnings visibility, and overall growth momentum.However, Procter & Gamble’s strong portfolio, innovation pipeline, and disciplined productivity efforts reinforce its ability to deliver sustainable growth. Procter & Gamble’s consistent execution positions it well to balance growth, resilience, and shareholder value creation. (You can read the full research report on Procter & Gamble here >>>)Comstock’s shares have outperformed the Zacks Building Products - Home Builders industry over the year-to-date period (+126.7% vs. +4.7%). Comstock benefits from stable, recurring revenue from asset management agreements extending through 2035, featuring cost-plus structures and performance incentives. Its debt-free, asset-light model enhances financial flexibility, while consistent revenue growth — 18.8% YoY in Q1 2025 — and expanding profitability demonstrate strong operational leverage. However, risks include revenue concentration with a related party, low third-party diversification, and deferred incentive fee recognition. Regulatory headwinds and heavy geographic concentration in the D.C. metro area pose additional exposure. (You can read the full research report on Comstock here >>>)Other noteworthy reports we are featuring today include Union Pacific Corp. (UNP), CVS Health Corp. (CVS) and Baker Hughes Co. (BKR).Mark VickerySenior EditorNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must ReadLilly (LLY) New Drugs to Drive Sales Growth Amid Rising CompetitionOracle (ORCL) Gains from Cloud Suite Adoption & PartnershipsProcter & Gamble's (PG) Solid Cash Flow Strengthens Investor AppealFeatured ReportsPlanned Investments, Permian Basin Focus Aid Occidental (OXY)Per the Zacks analyst, Occidental's investments to strengthen infrastructure and expansion of Permian Basin operation through acquisition will drive its performance over the long run.Union Pacific (UNP) Rides on Dividends & Buybacks, Amid Low VolumesThe Zacks analyst is impressed with the company's efforts to reward its shareholders. Sluggish volumes and high debt, however, represent major headwinds.NETGEAR (NTGR) Gains Strength in NFB & Recurring RevenuesPer the Zacks analyst, NETGEAR's performance gains from NFB unit, driven by momentum in ProAV products and recurring revenues. However, competition and weakness in Mobile segment remain concerns. A Solid Product Portfolio Aids Inogen (INGN) Amid Stiff CompetitionThe Zacks analyst is upbeat about Inogen's expanding product portfolio despite its operation in a competitive long-term oxygen therapy space.Solid Enterprise Strategy Aids Owens Corning (OC), Costs HurtPer the Zacks analyst, Owens Corning is gaining from streamlining operations and focusing on high-margin products. However, a soft housing market and high-cost inflation are concerning.Increasing LNG Demand to Aid Baker Hughes' (BKR) GrowthBaker Hughes' leadership in the LNG space, where demand is expected to strengthen, should drive long-term profitability. However, softening North American revenues concerns the Zacks analyst.CVS Health (CVS) Gains From Digital, Pharma and ServicesThe Zacks analyst is impressed with CVS Health's digital momentum, cost savings plan, Medicare margin recovery and strong growth in pharmacy, biosimilars and healthcare services.New UpgradesCanadian Natural (CNQ) to Gain from Recent Asset AcquisitionThe Zacks analyst believes that Canadian Natural's recent acquisitions of Palliser and Montney assets will enhance its production and reserve base resulting in increased profitability.Virtu Financial (VIRT) Gains from Market Making SegmentPer the Zacks analyst, the Market Making segment is well-poised for growth courtesy of growing retail engagement. Higher commissions have been driving results at its Execution Services segment.Product Diversification Efforts Aid Robinhood (HOOD) Top LinePer the Zacks analyst, Robinhood's efforts to diversify products to win new clients and gain market share will aid growth. Expansionary initiatives will likely deepen its global presence.New DowngradesRising Medical Costs & High Debt Ail Elevance Health (ELV)Per the Zacks analyst, the growing utilization trend is likely to continue increasing medical costs for Elevance, slashing its margins. Also, high leverage can affect its financial flexibility.Gap (GAP) Faces Demand Pressures, Clouding Its Sales GrowthPer the Zacks analyst, Gap's modest sales growth in Q1 stemmed from operational efficiencies rather than strong consumer demand. Heavier promotions and weak consumer trends weigh on its sales outlook.Weak Demand, Inventory Actions Ail Celanese (CE)Per the Zacks analyst, weaker end-market demand is likely to weigh on the company's volumes. Its inventory reduction actions to match demand are also expected to hurt earnings.Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Procter & Gamble Company (The) (PG): Free Stock Analysis Report Eli Lilly and Company (LLY): Free Stock Analysis Report Union Pacific Corporation (UNP): Free Stock Analysis Report CVS Health Corporation (CVS): Free Stock Analysis Report Oracle Corporation (ORCL): Free Stock Analysis Report Baker Hughes Company (BKR): Free Stock Analysis Report Comstock Holding Companies, Inc. (CHCI): Get Free ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks